Tower Research Capital (TRC)’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-902
| Closed | -$3.99K | – | 5695 |
|
|
2025
Q1 | $3.99K | Sell |
902
-247
| -21% | -$1.06K | ﹤0.01% | 4320 |
|
|
2024
Q4 | $4.56K | Buy |
1,149
+114
| +11% | +$462 | ﹤0.01% | 4441 |
|
|
2024
Q3 | $4.11K | Sell |
1,035
-674
| -39% | -$2.47K | ﹤0.01% | 4669 |
|
|
2024
Q2 | $6.31K | Buy |
1,709
+64
| +4% | +$255 | ﹤0.01% | 4594 |
|
|
2024
Q1 | $6.99K | Buy |
1,645
+608
| +59% | +$2.11K | ﹤0.01% | 4281 |
|
|
2023
Q4 | $3.73K | Buy |
1,037
+550
| +113% | +$2.31K | ﹤0.01% | 5046 |
|
|
2023
Q3 | $2.79K | Buy |
487
+238
| +96% | +$1.54K | ﹤0.01% | 5100 |
|
|
2023
Q2 | $1.94K | Sell |
249
-675
| -73% | -$6.24K | ﹤0.01% | 5292 |
|
|
2023
Q1 | $11K | Buy |
924
+76
| +9% | +$1.03K | ﹤0.01% | 4294 |
|
|
2022
Q4 | $10K | Buy |
848
+821
| +3,041% | +$11.7K | ﹤0.01% | 4111 |
|
|
2022
Q3 | $1K | Buy |
+27
| New | +$741 | ﹤0.01% | 5893 |
|
|
2022
Q2 | – | Sell |
-72
| Closed | -$2K | – | 6694 |
|
|
2022
Q1 | $2K | Buy |
+72
| New | +$2.56K | ﹤0.01% | 5638 |
|
|
2021
Q4 | – | Sell |
-150
| Closed | -$12K | – | 6716 |
|
|
2021
Q3 | $12K | Buy |
150
+98
| +188% | +$8.77K | ﹤0.01% | 4184 |
|
|
2021
Q2 | $1K | Buy |
+52
| New | +$1.33K | ﹤0.01% | 5288 |
|
|
2021
Q1 | – | Sell |
-818
| Closed | -$21K | – | 5824 |
|
|
2020
Q4 | $21K | Buy |
818
+635
| +347% | +$10.4K | ﹤0.01% | 3851 |
|
|
2020
Q3 | $2K | Buy |
+183
| New | +$2.76K | ﹤0.01% | 4635 |
|
|
2016
Q3 | – | Sell |
-3
| Closed | -$3K | – | 4632 |
|
|
2016
Q2 | $3K | Buy |
+3
| New | +$3.42K | ﹤0.01% | 3762 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5118 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5176 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5163 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 5051 |
|
|
2014
Q4 | – | Hold |
0
| – | -$1K | – | 4825 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 4185 |
|
|
2013
Q4 | – | Hold |
0
| – | -$2K | – | 4999 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 4155 |
|
Tower Research Capital (TRC)'s NURO Position: Q2 2025 in Review
Tower Research Capital (TRC) sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2025, closing a stake of 902 shares — an estimated $3.99K sold.
Tower Research Capital (TRC) first reported a position in NURO in Q2 2016 and held it in 17 quarters. The position peaked at $21K in Q4 2020. 0 funds tracked by Wall St. Rank hold NURO as of Q2 2025.
- Tower Research Capital (TRC) reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 902 NeuroMetrix, Inc. Common Stock shares in Q2 2025, an estimated $3.99K.
- Tower Research Capital (TRC) first reported a position in NeuroMetrix, Inc. Common Stock in Q2 2016 and held it in 17 quarters.
- Tower Research Capital (TRC)'s NeuroMetrix, Inc. Common Stock position peaked at $21K in Q4 2020.
- 0 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.